Trials / Unknown
UnknownNCT03831685
Blood Lactate Level for Pre-hospital Orientation of Septic Shock
Contribution of Pre-hospital Blood Lactate Level for Pre-hospital Orientation of Septic Shock
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Hôpital Necker-Enfants Malades · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
In the pre-hospital setting, the severity assessment of septic shock is essential to decide the optimal initial in-hospital level of care. As clinical signs can be faulted, there is a need for an additional element in order to enhance the severity assessment and to decide in-hospital admission in the intensive care unit (ICU) or in the emergency department (ED). Point of care medical device yielding blood lactate levels since the pre-hospital setting may give an easy and valuable element for the severity assessment and the decision-making. The aim of this study is to provide clinical evidence that the pre-hospital blood lactate level predicts the 30-day mortality of patients with septic shock.
Detailed description
This trial is a prospective, observational, non-randomized controlled study. A total of 1000 patients requiring mobile intensive care unit intervention for a septic shock in the pre-hospital setting will be included. Pre-hospital blood lactate levels will not be taken into account to decide patients treatments and/or ED or ICU admission. In the pre-hospital setting, each patient will benefit from 2 measurements of blood lactate level: initial measurement at the first contact, and final measurement at the hospital admission with a specific point of care medical device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood sample | Patients meeting the inclusion criteria and none of the non-inclusion criteria will benefit from 2 venous blood samples in order to precise the initial blood lactate level, e.g. at the first medical contact, and the final blood lactate level, e.g. at the hospital admission. |
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2022-03-01
- Completion
- 2022-03-01
- First posted
- 2019-02-06
- Last updated
- 2019-02-11
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03831685. Inclusion in this directory is not an endorsement.